Please use this identifier to cite or link to this item:
https://nslhd.intersearch.com.au/nslhdjspui/handle/1/36412
Title: | Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis | Authors: | Sammel, Anthony M. ;Hsiao, Edward ;Schembri, Geoffrey ;Bailey, Elizabeth ;Nguyen, Katherine ;Brewer, Janice ;Schrieber, Leslie ;Janssen, Beatrice ;Youssef, Peter;Fraser, Clare L. ;Laurent, Rodger | Affiliation: | Royal North Shore Hospital | Department: | Rheumatology Nuclear Medicine Anatomical Pathology |
Issue Date: | Apr-2020 | Publication information: | 23(4):582-588 | Journal: | International Journal of Rheumatic Diseases | Abstract: | Aim: Positron emission tomography/computed tomography (PET/CT) can detect cranial and large vessel inflammation in giant cell arteritis (GCA). We aimed to determine the change and significance of vascular activity at diagnosis and 6 months. Method(s): Newly diagnosed GCA patients underwent time-of-flight fluorine-18-fluoro-2-deoxyglucose PET/CT from vertex to diaphragm within 72 hours of commencing corticosteroids and were followed for 12 months. A 6 months scan was performed in patients with inflammatory features on biopsy or CT aortitis. Vascular uptake was visually graded by 2 blinded readers across 18 artery segments from 0 (no increased uptake) to 3 (very marked uptake). Scores were summed to give a total vascular score (TVS). Result(s): We enrolled 21 GCA patients and 15 underwent the serial scan. Twelve (57%) patients experienced a relapse and 5 of these had ischemic features of vision disturbance, jaw or limb claudication. The median TVS fell from 14 (interquartile range [IQR] 4-24) at baseline to 5 (IQR 0-10) at 6 months (P <.01) with reduction in both cranial and large artery scores. While the overall relapse rate was similar between patients with a high (>=10) and low baseline TVS, patients with high scores were numerically more likely to experience an ischemic relapse (33% vs 11%, P =.34). Five out of 15 patients had persistent uptake in at least 1 vessel on the serial PET/CT but none experienced a subsequent relapse. Conclusion(s): Vascular activity decreased in cranial and large arteries between diagnosis and 6 months. Persistent activity did not predict subsequent relapse. Copyright © 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd | URI: | https://nslhd.intersearch.com.au/nslhdjspui/handle/1/36412 | DOI: | 10.1111/1756-185X.13805 | URL: | https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13805 | Type: | Article | AHT Subjects: | Vasculitis Positron Emission Tomography Prognosis |
Keywords: | Female;giant cell arteritis/di [Diagnosis];giant cell arteritis/dt [Drug Therapy];headache;Humans;Male;positron emission tomography-computed tomography;prognosis;relapse;rheumatic polymyalgia;scoring system;time of flight mass spectrometry;treatment duration;visual disorder/di [Diagnosis];C reactive protein/ec [Endogenous Compound];fluorodeoxyglucose f 18/pv;methylprednisolone/dt [Drug Therapy];methylprednisolone/iv [Intravenous Drug Administration];methylprednisolone/pv [Special Situation for Pharmacovigilance];PET-CT scanner;total vascular score;drug megadose;disease burden;cohort analysis;clinical article;claudication/di [Diagnosis];brain artery;biopsy;erythrocyte sedimentation rate |
Appears in Collections: | Research Publications |
Show full item record
Items in NSLHD are protected by copyright, with all rights reserved, unless otherwise indicated.